SDS

Oral (Mouse) LD50; 2200 mg/kg
[2]
Skin: adverse effect observed (irritating)
[1]
MDI, propoxylated
TOXICITY
IRRITATION
Not Available
Not Available
MDI homopolymer
TOXICITY
IRRITATION
Oral (Rat) LD50: >5000 mg/kg
[1]
Eye: no adverse effect observed (not irritating)
[1]
Skin: adverse effect observed (irritating)
[1]
zeolites
TOXICITY
IRRITATION
Dermal (rabbit) LD50: >2000 mg/kg
[2]
Not Available
Inhalation(Rat) LC50: >0.5 mg/l4h
[2]
Oral (Rat) LD50: >2000 mg/kg
[1]
Talc
TOXICITY
IRRITATION
dermal (rat) LD50: >2000 mg/kg
[1]
Eye: no adverse effect observed (not irritating)
[1]
Inhalation(Rat) LC50: >2.1 mg/l4h
[1]
Skin: no adverse effect observed (not irritating)
[1]
Oral (Rat) LD50: >5000 mg/kg
[1]
MDI, propylene glycol,
trimethylolpropane,triether
TOXICITY
IRRITATION
Not Available
Not Available
silica amorphous
TOXICITY
IRRITATION
dermal (rat) LD50: >2000 mg/kg
[1]
Eye (rabbit): non-irritating ** [Grace]
Inhalation(Rat) LC50: >0.09<0.84 mg/l4h
[1]
Eye: no adverse effect observed (not irritating)
[1]
Oral (Rat) LD50: >1000 mg/kg
[1]
Skin (rabbit): non-irritating *
Skin: no adverse effect observed (not irritating)
[1]
propylene carbonate
TOXICITY
IRRITATION
Dermal (rabbit) LD50: >=2000 mg/kg
[1]
Eye (rabbit): 60 mg - moderate
Oral (Rat) LD50: >5000 mg/kg
[1]
Eye: adverse effect observed (irritating)
[1]
Skin (human): 100 mg/3d-I moderate
Skin (rabbit): 500 mg moderate
Skin: no adverse effect observed (not irritating)
[1]
Legend:
1. Value obtained from Europe ECHA Registered Substances - Acute toxicity 2. Value obtained from manufacturer's SDS. Unless otherwise
specified data extracted from RTECS - Register of Toxic Effect of chemical Substances
4,4'-DIPHENYLMETHANE
DIISOCYANATE (MDI)
Inhalation (human) TCLo: 0.13 ppm/30 mins Eye (rabbit): 0.10 mg moderate
Aromatic and aliphatic diisocyanates may cause airway toxicity and skin sensitization. Monomers and prepolymers exhibit similar
respiratory effect. Of the several members of diisocyanates tested on experimental animals by inhalation and oral exposure, some caused
cancer while others produced a harmless outcome.
MDI HOMOPOLYMER
as polymethylene polyphenyl isocyanate
ZEOLITES
Inhalation (-) LC50: >18.3 mg/l/1hr for sodium aluminosilicate, zeolite A: Skin (rabbit): non-irritating Eye (rabbit): slight [Grace]
SILICA AMORPHOUS
Reports indicate high/prolonged exposures to amorphous silicas induced lung fibrosis in experimental animals; in some experiments these
effects were reversible. [PATTYS]
PROPYLENE CARBONATE
WARNING:
This substance has been classified by the IARC as Group 2B: Possibly Carcinogenic to Humans.
The material may cause skin irritation after prolonged or repeated exposure and may produce on contact skin redness, swelling, the
production of vesicles, scaling and thickening of the skin.
for propylene carbonate:
Numerous adequate and reliable acute toxicity tests are available on propylene carbonate. Oral and dermal tests meet OECD and EPA test
guidelines. Propylene carbonate is practically nontoxic following acute exposures; the oral LD50 is >.5000 mg/kg and the dermal LD50 is
>3000 mg/kg.
PlasticBonder™ Syringe Black -
Part A & 4,4'-DIPHENYLMETHANE
DIISOCYANATE (MDI) & MDI,
PROPOXYLATED & MDI
HOMOPOLYMER & MDI,
PROPYLENE GLYCOL,
TRIMETHYLOLPROPANE,TRIETHER
Asthma-like symptoms may continue for months or even years after exposure to the material ends. This may be due to a non-allergic
condition known as reactive airways dysfunction syndrome (RADS) which can occur after exposure to high levels of highly irritating
compound. Main criteria for diagnosing RADS include the absence of previous airways disease in a non-atopic individual, with sudden
onset of persistent asthma-like symptoms within minutes to hours of a documented exposure to the irritant.
Allergic reactions involving the respiratory tract are usually due to interactions between IgE antibodies and allergens and occur rapidly.
Allergic potential of the allergen and period of exposure often determine the severity of symptoms. Some people may be genetically more
prone than others, and exposure to other irritants may aggravate symptoms.
Version No:
11.16
Page
9
of
14
PlasticBonder™ Syringe Black - Part A
Issue Date:
12/07/2023
Print Date:
12/07/2023
Continued...